Technologies for localization and diagnosis of prostate cancer

Journal of Medical Engineering and Technology

Volumn 33, Issue 8, 2009, Pages 585-603

  Candefjord, S ^a   Ramser, K ^a   Lindahl, O A ^a  

^a LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Diagnosing; Grading; Imaging; Prostate cancer; Targeted biopsy

Indexed keywords

DIAGNOSING; ELASTOGRAPHY; EXPERIMENTAL TECHNIQUES; GOLD STANDARDS; IMAGING; IN-VITRO; PROSTATE CANCER; PROSTATE CANCERS; RESONANCE SENSOR; TARGETED BIOPSY;

ACOUSTIC WAVES; BIOPSY; RESONANCE; ULTRASONIC APPLICATIONS; ULTRASONIC IMAGING; ULTRASONICS; VIBRATIONAL SPECTROSCOPY;

SENSORS;

PROSTATE SPECIFIC ANTIGEN;

ARTIFICIAL NEURAL NETWORK; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DOPPLER FLOWMETRY; ELASTOGRAPHY; HUMAN; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

BIOPSY; BIOTECHNOLOGY; CONTRAST MEDIA; DIAGNOSIS, COMPUTER-ASSISTED; ELASTICITY IMAGING TECHNIQUES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; SPECTROPHOTOMETRY, INFRARED; SPECTRUM ANALYSIS, RAMAN; ULTRASONOGRAPHY, DOPPLER;

EID: 70350492898     PISSN: 03091902     EISSN: 1464522X     Source Type: Journal    
DOI: 10.3109/03091900903111966     Document Type: Review

References (185)

1. Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M. and Boyle, P., 2007, Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology, 18, 581-592. (Pubitemid 46359643)
2. Fitzsimons, N.J., Sun, L. and Moul, J.W., 2007, Medical technologies for the diagnosis of prostate cancer. Expert Review of Medical Devices, 4, 227-239. (Pubitemid 46522770)
3. Sim, H.G. and Cheng, C.W.S., 2005, Changing demography of prostate cancer in Asia. European Journal of Cancer, 41, 834-845. (Pubitemid 40467547)
4. Olsson, C., 1993, Prostatic cancer. Kidney International, 43, 955-965.
5. Hricak, H., Choyke, P.L., Eberhardt, S.C., Leibel, S.A. and Scardino, P.T., 2007, Imaging prostate cancer: A multidisciplinary perspective. Radiology, 243, 28-53. (Pubitemid 46579693)
6. Kundra, V., 2006, Prostate cancer imaging. Seminars in Roentgenology, 41, 139-149.
7. Loch, T., 2007, Urologie imaging for localized prostate cancer in 2007. World Journal of Urology, 25, 121-129.
8. Fuchsjäger, M., Shukla-Dave, A., Akin, O., Barentsz, J. and Hricak, H., 2008, Prostate cancer imaging. Acta Radiology, 49, 107-120.
9. Kim, C.K. and Park, B.K., 2008, Update of prostate magnetic resonance imaging at 3T. Journal of Computer Assisted Tomography, 32, 163-172.
10. Kurhanewicz, J., Vigneron, D., Carroll, P. and Coakley, F., 2008, Multiparametric magnetic resonance imaging in prostate cancer: present and future. Current Opinions in Urology, 18, 71-77. (Pubitemid 350307535)
11. Pallwein, L., Mitterberger, M., Pelzer, A., Bartsch, G., Strasser, H., Pinggera, G.M., Aigner, F., Gradl, J., Nedden, D.Z. and Frauscher, F., 2008, Ultrasound of prostate cancer: recent advances. European Radiology, 18, 707-715.
12. Costello, L.C. and Franklin, R.B., 2009, Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem. Prostate Cancer and Prostatic Diseases, 12, 17-24.
13. De Angelis, G., Rittenhouse, H.G., Mikolajczyk, S.D., Blair Shamel, L., and Semjonow, A., 2007, Twenty years of PSA: from prostate antigen to tumor marker. Reviews in Urology, 9, 113-123.
14. McNeal, J.E., Redwine, E.A., Freiha, F.S. and Stamey, T.A., 1988, Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. American Journal of Surgical Pathology, 12, 897-906.
15. Boczko, J., Messing, E. and Dogra, V., 2006, Transrectal sonography in prostate evaluation. Radiologic Clinics of North America, 44, 679-687.
16. Gjengstø, P., Halvorsen, O.J., Akslen, L.A., Frugård, J. and Hoisaeter, P.A., 2003, Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients. Urology, 62, 447-450.
17. Tang, J., Yang, J.C., Zhang, Y., Liu, X., Zhang, L., Wang, Z., Li, J., Luo, Y., Xu, J. and Shi, H., 2007, Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study. BJU International, 100, 1091-1096. (Pubitemid 47537644)
18. Halpern, E.J., 2006, Contrast-enhanced ultrasound imaging of prostate cancer. Reviews in Urology, 8 Suppl 1, S29-S37.
19. Neal, D.E., Leung, H.Y., Powell, P.H., Hamdy, F.C. and Donovan, J.L., 2000, Unanswered questions in screening for prostate cancer. European Journal of Cancer, 36, 1316-1321.
20. Zhu, Y., Williams, S. and Zwiggelaar, R., 2006, Computer technology in detection and staging of prostate carcinoma: a review. Medical Image Analysis, 10, 178-199. (Pubitemid 43174973)
21. Bergh, A., Grönberg, H., Hedestig, O., Stattin, P., Widmark, A. and Wikström, P., 2005, Prostatacancer - Mannens Gissel. (Umeâ: Faculty of Medicine at Umeå University).
22. Raja, J., Ramachandran, N., Munneke, G. and Patel, U., 2006, Current status of transrectal ultrasound guided prostate biopsy in the diagnosis of prostate cancer. Clinical Radiology, 61, 142-153. (Pubitemid 43137193)
23. Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B. and Lindahl, O.A., 2006, Resonance sensor measurements of stiffness variations in prostate tissue in vitro-a weighted tissue proportion model. Physiological Measurement, 27, 1373-1386. (Pubitemid 46064272)
24. Miyanaga, N., Akaza, H., Yamakawa, M., Oikawa, T., Sekido, N., Hinotsu, S., Kawai, K., Shimazui, T. and Shiina, T., 2006, Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report. International Journal of Urology, 13, 1514-1518. (Pubitemid 44786339)
25. Zhang, M., Nigwekar, P., Castaneda, B., Hoyt, K., Joseph, IV., di Sant'Agnese, A., Messing, E.M., Strang, J.G., Rubens, D.J. and Parker, K.J., 2008, Quantitative characterization of viscoelastic properties of human prostate correlated with histology. Ultrasound in Medicine and Biology, 34, 1033-1042. (Pubitemid 351893146)
26. Heidenreich, A., Aus, G., Bolla, M., Joniau, S., Matveev, V.B., Schmid, H.P. and Zattoni, F., 2008, EAU guidelines on prostate cancer. European Urology, 53, 68-80.
27. Hodge, K.K., McNeal, J.E., Terris, M.K. and Stamey, T.A., 1989, Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. Journal of Urology, 142, 71-74; discussion 74-75.
28. Rabbani, F., Stroumbakis, N., Kava, B.R., Cookson, M.S. and Fair, W.R., 1998, Incidence and clinical significance of false-negative sextant prostate biopsies. Journal of Urology, 159, 1247-1250. (Pubitemid 28172807)
29. Jones, I.S., Patel, A., Schoenfield, L., Rabets, I.C., Zippe, CD. and Magi-Galluzzi, C., 2006, Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. Journal of Urology, 175, 485-488. (Pubitemid 43067334)
30. Lane, B.R., Zippe, C.D., Abouassaly, R., Schoenfield, L., MagiGalluzzi, C. and Jones, J.S., 2008, Saturation technique does not decrease cancer detection during follow up after initial prostate biopsy. Journal of Urology, 79, 1746-1750.
31. Kirkham, A.P.S., Emberton, M. and Allen, C., 2006, How good is MRI at detecting and characterising cancer within the prostate? European Urology, 50, 1163-1174; discussion 1175. (Pubitemid 44692933)
32. Catalona, W.J., Loeb, S. and Han, M., 2006, Viewpoint: expanding prostate cancer screening. Annals of Internal Medicine, 144, 441-443.
33. Helzlsouer, K.J., Newby, J. and Comstock, G.W., 2008, Prostatespecific antigen levels and subsequent prostate cancer: potential for screening. American Journal Of Epidemiology, 168, 841-844 (reprinted from Cancer Epidemiology, Biomarkers & Prevention, 1992, 1, 537-540).
34. USPSTF, 2008, Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 149, 185-191.
35. Ahyai, S.A., Graefen, M., Steuber, T., Haese, A., Schlomm, T., Walz, J., Köllermann, J., Briganti, A., Zacharias, M., Friedrich, M.G., Karakiewicz, P.I., Montorsi, F., Huland, H. and Chun, F.K.-H., 2008, Contemporary prostate cancer prevalence among Tic biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter. European Urology, 53, 750-757.
36. Thompson, I.M., Pauler, D.K., Goodman, P.J., Tangen, C.M., Lucia, M.S., Pames, H.L., Minasian, L.M., Ford, L.G., Lippman, S.M., Crawford, E.D., Crowley, J.J., and Coltman, CA., 2004, Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. New England Journal of Medicine, 350, 2239-2246.
37. Montironi, R., Mazzuccheli, R., Scarpelli, M., Lopez-Beltran, A., Fellegara, G., and Algaba, F., 2005, Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies. BJU International, 95, 1146-1152. (Pubitemid 40799472)
38. Coard, K.C. and Freeman, V.L., 2004, Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies. American Journal of Clinical Pathology, 122, 373-376.
39. Fukagai, T., Namiki, T., Namiki, H., Carlile, R.G., Shimada, M. and Yoshida, H., 2001, Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathology International, 51, 364-370. (Pubitemid 32589024)
40. Maygarden, S.J. and Pruthi, R., 2005, Gleason grading and volume estimation in prostate needle biopsy specimens: evolving issues. American Journal of Clinical Pathology, 123 Suppl, S58-S66.
41. Ooi, K. and Samali, R., 2007, Discrepancies in Gleason scoring of prostate biopsies and radical prostatectomy specimens and the effects of multiple needle biopsies on scoring accuracy .A regional experience in Tamworth, Australia. ANZ Journal of Surgery, 77, 336-338. (Pubitemid 46709707)
42. Tomioka, S., Nakatsu, H., Suzuki, N., Murakami, S., Matsuzaki, O. and Shimazaki, J., 2006, Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer. International Journal of Urology, 13, 555-559. (Pubitemid 43760419)
43. Aihara,M.,Wheeler,T.M.,Ohori,M.andScardino,P.T.,1994, Heterogeneityofprostatecancerinradicalprostatectomyspecimens.Urology,43, 60-66;discussion66-67.(Pubitemid24044315)
44. Sooriakumaran, P., Lovell, D.P., Henderson, A., Denham, P., Langley, S.E.M. and Laing, R.W., 2005, Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer. Clinical Oncology, 17, 655-658. (Pubitemid 41700333)
45. Dall'Era, M.A., Konety, B.R., Cowan, J.E., Shinohara, K., Stauf, F., Cooperberg, M.R., Meng, M.V., Kane, C.J., Perez, N., Master, V.A. and Carroll, P.R., 2008, Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer, 112, 26642670. (Pubitemid 351969209)
46. Yin, M., Bastacky, S., Chandran, U., Becich, M.J. and Dhir, R., 2008, Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. Journal of Urology, 179, 892-895; discussion 895.
47. Watanabe, H., Kaiho, H., Tanaka, M. and Terasawa, Y., 1971, Diagnostic application of ultrasonotomography to the prostate. Investigative Urology, 8, 548-559.
48. Watanabe, H., Igari, D., Tanahashi, Y., Harada, K. and Saito, M., 1974, Measurements of size and weight of prostate by means of transrectal ultrasonotomography. Tohoku Journal of Experimental Medicine, 114, 277-285.
49. Watanabe, H., Igari, D., Tanahashi, Y., Harada, K., and Saitoh, M., 1975, Transrectal ultrasonotomography of the prostate. Journal of Urology, 114, 734-739.
50. Watanabe, H., Igari, D., Tanahashi, Y., Harada, K. and Saitoh, M., 1976, An evaluation of the function of new special equipment for transrectal ultrasonotomography. Tohoku Journal of Experimental Medicine, 118, 387-392.
51. Toi, A., Neill, M.G., Lockwood, G.A., Sweet, J.M., Tammsalu, L.A. and Fleshner, N.E., 2007, The continuing importance of transrectal ultrasound identification of prostatic lesions. Journal of Urology, 177, 516-520. (Pubitemid 46054011)
52. Oyen, R.H., Van de Voorde, W.M., Van Poppel, H.P., Brys, P.P., Ameye, F.E., Franssens, Y.M., Baert, A.L. and Baert, L.V., 1993, Benign hyperplastic nodules that originate in the peripheral zone of the prostate gland. Radiology, 189, 707-711.
53. Lee,F.,Torp-Pedersen,S.,Littrup,P.J.,McLeary,R.D.,McHugh,T.A.,Smid,A.P., Stella,P.J.andBorlaza,G.S.,1989,Hypoechoiclesionsoftheprostate: clinicalrelevanceoftumorsize,digitalrectalexamination,andprostate- specificantigen.Radiology,170,29-32.(Pubitemid19016839)
54. Carter,H.B.,Hamper,U.M.,Sheth,S.,Sanders,R.C.,Epstein,J.J.andWalsh,P.C., 1989,Evaluationoftransrectalultrasoundintheearlydetectionofprostatecancer. JournalofUrology,142,1008-1010.(Pubitemid19250753)
55. Flanigan, R.C., Catalona, W.J., Richie, J.P., Ahmann, F.R., Hudson, M.A., Scardino, P.T., deKernion, J.B., Ratliff, T.L., Kavoussi, L.R. and Dalkin, B.L., 1994, Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. Journal of Urology, 152, 1506-1509.
56. Carey, B.M., 2005, Imaging for prostate cancer. Clinical Oncology, 17, 553-559.
57. Mohamed, S.S., Salama, M.M.A., Kamel, M., El-Saadany, E.F., Rizkalla, K. and Chin, J. 2005, Prostate cancer multi-feature analysis using trans-rectal ultrasound images. Physics in Medicine and Biology, 50, N175-N185.
58. Padhani, A.R., Harvey, C.J. and Cosgrove, D.O., 2005, Angiogenesis imaging in the management of prostate cancer. Nature Clinical Practice Urology, 2, 596-607.
59. Bude, R.O. and Rubin, J.M., 1996, Power Doppler sonography. Radiology, 200, 21-23.
60. Rubin,J.M.,Bude,R.O.,Carson,P.L.,Bree,R.L.andAdler,R.S.,1994, PowerDopplerUS:apotentiallyusefulalternative-meanfrequency-basedcolorDopplerUS. Radiology,190,853-856.(Pubitemid24071059)
61. Amiel, G.E. and Slawin, K.M., 2006, Newer modalities of ultrasound imaging and treatment of the prostate. Urologie Clinics of North America, 33, 329-337.
62. Arger, P.H., Malkowicz, S.B., Van Arsdalen, K.N., Sehgal, C.M., Holzer, A. and Schultz, S.M., 2004, Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity. Journal of Ultrasound Medicine, 23, 623-630.
63. Halpern, E.J. and Strup, S.E., 2000, Using gray-scale and color and power Doppler sonography to detect prostatic cancer. American Journal of Roentgenology, 174, 623-627.
64. Sauvain, J.L., Palascak, P., Bourscheid, D., Chabi, C., Atassi, A., Bremon, J.M. and Palascak, R., 2003, Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. European Urology, 44, 21-30; discussion 30-31
65. Sauvain, J.L., Palascak, P., Nader, N., Gomez, W., Bloqueau, Ph., Bremon, J.M., Jung, L., Maniere, Ph. and Papavero, R., 2006, Power Doppler Imaging and prostate cancer: optional or necessary technique? Journal of Radiology, 87, 1063-1072.
66. Berger, A.P., Horninger, W., Bektic, J., Pelzer, A., Spranger, R., Bartsch, G. and Frauscher, F., 2006, Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU International, 98, 587590. (Pubitemid 44185881)
67. Kojima,M.,Ochiai,A.,Naya,Y.,Okihara,K.,Ukimura,O.andMiki,T.,2000, Dopplerresistiveindexinbenignprostatichyperplasia: correlationwithultrasonicappearanceoftheprostateandinfravesicalobstruction. EuropeanUrology,37,436-442.(Pubitemid30157805)
68. Turgut,A.T.,Olücüoglu,E.,Kosar,P.,Geyik,P.O.,Kosar,U.andDogra, V.,2007,PowerDopplerultrasonographyofthefeedingarteriesoftheprostategland: anovelapproach-thediagnosisofprostatecancer?JournalofUltrasoundMedicine,26, 875-883.(Pubitemid47036109)
69. Frauscher, F., Klauser, A., Halpern, E.J., Horninger, W. and Bartsch, G., 2001, Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet, 357, 1849-1850. (Pubitemid 32539119)
70. Frauscher,F.,Klauser,A.,Volgger,H.,Halpern,E.J.,Pallwein,L.,Steiner,H., Schuster,A.,Horninger,W.,Rogatsch,H.andBartsch,G.,2002, ComparisonofcontrastenhancedcolorDoppler targetedbiopsywithconventionalsystematicbiopsy:impactonprostatecancerdetection. JournalofUrology,167,1648-1652.(Pubitemid34240691)
71. Mitterberger, M., Pinggera, G.M., Horninger, W., Bartsch, G., Strasser, H., Schäfer, G., Brunner, A., Halpern, E.J., Gradl, J., Pallwein, L. and Frauscher, F., 2007, Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. Journal of Urology, 178, 464-468; discussion 468.
72. Mitterberger, M., Horninger, W., Pelzer, A., Strasser, H., Bartsch, G., Moser, P., Halpern, E.J., Gradl, J., Aigner, F., Pallwein, L. and Frauscher, F., 2007, A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection. Prostate, 67, 1537-1542.
73. Mitterberger, M., Pinggera, G., Horninger, W., Strasser, H., Halpern, E., Pallwein, L., Gradl, J., Bartsch, G. and Frauscher, F., 2008, Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection. European Urology, 53, 112-117. (Pubitemid 350166703)
74. Halpern,E.J.,Frauscher,F.,Rosenberg,M.andGomella,L.G.,2002, Directedbiopsyduringcontrast-enhancedsonographyoftheprostate. AmericanJournalofRoentgenology,178,915-919.(Pubitemid34250229)
75. Halpern, E.J., Ramey, J.R., Strup, S.E., Frauscher, F., McCue, P. and Gomella, L.G., 2005, Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer, 104, 2373-2383. (Pubitemid 41691558)
76. Halpern,E.J.,McCue,P.A.,Aksnes,A.K.,Hagen,E.K.,Frauscher,F.andGomella,L. G.,2002,Contrast-enhancedUSoftheprostatewithSonazoid:comparisonwithwhole- mountprostatectomyspecimensin12patients.Radiology,222,361-366. (Pubitemid34106105)
77. Wink, M., Frauscher, F., Cosgrove, D., Chapelon, J.-Y., Palwein, L., Mitterberger, M., Harvey, C., Rouviere, O., de la Rosette, J. and Wijkstra, H., 2008, Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. European Urology, 54, 982-993.
78. Phillips, P. and Gardner, E., 2004, Contrast-agent detection and quantification. European Radiology, 14 Suppl 8, P4-10.
79. Yang, J.C., Tang, J., Li, J., Luo, Y., Li, Y. and Shi, H., 2008, Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels. Academic Radiology, 15, 1291-1297.
80. Mehta, S.S., Azzouzi, A.R. and Hamdy, F.C., 2004, Three dimensional ultrasound and prostate cancer. World Journal of Urology, 22, 339-345.
81. Sedelaar, J.P., van Roermund, J.G., van Leenders, G.L., Hulsbergenvan de Kaa, C.A., Wijkstra, H. and de la Rosette, J.J., 2001, Threedimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology, 57, 914-920.
82. Bogers, H.A., Sedelaar, J.P., Beerlage, H.P., de la Rosette, J.J., Debruyne, F.M., Wijkstra, H. and Aarnink, R.G., 1999, Contrastenhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology, 54, 97-104. (Pubitemid 29323340)
83. Sedelaar, J.P.M., van Leenders, G.J.L.H., Goossen, T.E.B., Hulsbergen-van der Kaa, C.A., van Adrichem, N.P., Wijkstra, H. and de la Rosette, J.J.M.C.H., 2002, Value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate, 53, 246-253.
84. Ophir, J., Cspedes, I., Ponnekanti, H., Yazdi, Y. and Li, X., 1991, Elastography: a quantitative method for imaging the elasticity of biological tissues. Ultrasonic Imaging, 13, 111-134.
85. König, K., Scheipers, U., Pesavento, A., Lorenz, A., Ermert, H. and Senge, T., 2005, Initial experiences with real-time elastography guided biopsies of the prostate. Journal of Urology, 174, 115-117. (Pubitemid 40825688)
86. Pallwein, L., Mitterberger, M., Struve, P., Pinggera, G., Horninger, W., Bartsch, G., Aigner, F., Lorenz, A., Pedross, F. and Frauscher, F., 2007, Real-time elastography for detecting prostate cancer: preliminary experience. BJU International, 100, 42-46. (Pubitemid 46878542)
87. Pallwein, L., Mitterberger, M., Struve, P., Horninger, W., Aigner, F., Bartsch, G., Gradl, J., Schurich, M., Pedross, F. and Frauscher, F., 2007, Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. European Radiology, 17, 2278-2285. (Pubitemid 47288264)
88. Pallwein, L., Mitterberger, M., Pinggera, G., Aigner, F., Pedross, F., Gradl, J., Pelzer, A., Bartsch, G. and Frauscher, F., 2008, Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. European Journal of Radiology, 65, 304-310. (Pubitemid 351179952)
89. Tsutsumi, M., Miyagawa, T., Matsumura, T., Kawazoe, N., Ishikawa, S., Shimokama, T., Shiina, T., Miyanaga, N. and Akaza, H., 2007, The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis. International Journal of Clinical Oncology, 12, 250-255.
90. Sumura, M., Shigeno, K., Hyuga, T., Yoneda, T., Shiina, H. and Igawa, M., 2007, Initial evaluation of prostate cancer with real-time elastography based on step-section pathologic analysis after radical prostatectomy: a preliminary study. International Journal of Urology, 14, 811-816. (Pubitemid 47313273)
91. Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B. and Lindahl, O.A., 2008, Explanatory models for a tactile resonance sensor system-elastic and density-related variations of prostate tissue in vitro. Physiological Measurement, 29, 729-745. (Pubitemid 352020305)
92. Omata, S. and Terunuma, Y., 1992, New tactile sensor like the human hand and its applications. Sensors and Actuators A, 35, 9-15. (Pubitemid 23557515)
93. Eklund,A.,Bergh,A.andLindahl,O.A.,1999, Acathetertactilesensorformeasuringhardnessofsofttissue: measurementinasiliconemodelandinaninvitrohumanprostatemodel.Medical& BiologicalEngineering&Computing,37,618-624.(Pubitemid29488399)
94. Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B. and Lindahl, O.A., 2006, Prostate tissue stiffness as measured with a resonance sensor system: a study on silicone and human prostate tissue in vitro. Medical & Biological Engineering & Computing, 44, 593-603. (Pubitemid 44184471)
95. Jalkanen, V., Andersson, B.M., Bergh, A., Ljungberg, B. and Lindahl, O.A., 2007, Spatial variations in prostate tissue histology as measured by a tactile resonance sensor. Physiological Measurement, 28, 1267-1281. (Pubitemid 350093346)
96. Lindberg, P., Andersson, B., Bergh, A., Ljungberg, B. and Lindahl, O.A., 2006, Prostate cancer detection with an improved resonance sensor system: parameter evaluation in a silicone model and on human prostate tissue in vitro. Medical & Biological Engineering & Computing, 44, 1053-1059. (Pubitemid 47096458)
97. Smith, R.C. and McCarthy, S., 1992, Physics of magnetic resonance. Journal of Reproductive Medicine, 37, 19-26.
98. Jordan, K.W. and Cheng, L.L., 2007, NMR-based metabolomics approach to target biomarkers for human prostate cancer. Expert Reviews in Proteomics, 4, 389-400. (Pubitemid 46890076)
99. Trabulsi, E.J., Merriam, W.G. and Gomella, L.G., 2006, New imaging techniques in prostate cancer. Current Urology Reports, 7, 175-180. (Pubitemid 44624001)
100. Oehr, P. and Bouchelouche, K., 2007, Imaging of prostate cancer. Current Opinions in Oncology, 19, 259-264.
101. Wefer,A.E.,Hricak,H.,Vigneron,D.B.,Coakley,F.V.,Lu,Y.,Wefer,J., Mueller-Lisse,U.,Carroll,P.R.andKurhanewicz,J.,2000, Sextantlocalizationofprostatecancer:comparisonofsextantbiopsy, magneticresonanceimagingandmagneticresonance spectroscopicimagingwithstepsectionhistology.JournalofUrology,164,400-404. (Pubitemid30481935)
102. Mullerad, M., Hricak, H., Kuroiwa, K., Pucar, D., Chen, H.-N., Kattan, M.W. and Scardino, P.T., 2005, Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. Journal of Urology, 174, 2158-2163. (Pubitemid 41611764)
103. Akin,O.,Sala,E.,Moskowitz,C.S.,Kuroiwa,K.,Ishill,N.M.,Pucar,D.,Scardino, P.T.andHricak,H.,2006,Transitionzoneprostatecancers:features,detection, localization,andstagingatendorectalMRimaging.Radiology,239,784-792. (Pubitemid43830614)
104. Casciani, E. and Gualdi, G., 2006, Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging. Abdominal Imaging, 31, 490-499. (Pubitemid 46352054)
105. Rajesh, A. and Coakley, F.V., 2004, MR imaging and MR spectroscopic imaging of prostate cancer. Magnetic Resonance Imaging Clinics of North America, 12, 557-579.
106. 3) spatial resolution. Radiology, 198, 795-805.
107. Jung, J.A., Coakley, F.V., Vigneron, D.B., Swanson, M.G., Qayyum, A., Weinberg, V., Jones, K.D., Carroll, P.R. and Kurhanewicz, J., 2004, Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology, 233, 701-708.
108. Fütterer, J.J., Scheenen, T.W.J., Heijmink, S.W.T.P.J., Huisman, H.J., de Kaa, C., Witjes, J.A., Heerschap, A. and Barentsz, J.O., 2007, Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Investigative Radiology, 42, 116-122. (Pubitemid 46104892)
109. Wang, P., Guo, Y., Liu, M., Qiang, Y., Guo, X., Zhang, Y., Duan, X.-Y., Zhang, Q.-J. and Liang, W., 2008, A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool. Korean Journal of Radiology, 9, 432-438.
110. Vilanova, J.C. and Barcel, J., 2007, Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging. Abdominal Imaging, 32, 253-261. (Pubitemid 46883672)
111. Scheidler,J.,Hricak,H.,Vigneron,D.B.,Yu,K.K.,Sokolov,D.L.,Huang,L.R., Zaloudek,C.J.,Nelson,S.J.,Carroll,P.R.andKurhanewicz,J.,1999,Prostatecancer: localizationwiththreedimensionalprotonMRspectroscopicimaging- clinicopathologicstudy.Radiology,213,473-480.(Pubitemid29510595)
112. Yu,K.K.,Scheidler,J.,Hricak,H.,Vigneron,D.B.,Zaloudek,C.J.,Males,R.G., Nelson,S.J.,Carroll,P.R.andKurhanewicz,J.,1999,Prostatecancer: predictionofextracapsularextensionwithendorectalMRimagingandthree- dimensionalprotonMRspectroscopicimaging.Radiology,213,481-488. (Pubitemid29510596)
113. Kurhanewicz,J.,Vigneron,D.B.andNelson,S.J.,2000, Threedimensionalmagneticresonancespectroscopicimagingofbrainandprostatecancer. Neoplasia,2,166-189.(Pubitemid30123187)
114. Zakian, K.L., Sircar, K., Hricak, H., Chen, H.-N., Shukla-Dave, A., Eberhardt, S., Muruganandham, M., Ebora, L., Kattan, M.W., Reuter, V.E., Scardino, P.T. and Koutcher, J.A., 2005, Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology, 234, 804-814. (Pubitemid 40250824)
115. Wang, L., Hricak, H., Kattan, M.W., Chen, H.-N., Scardino, P.T. and Kuroiwa, K., 2006, Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology, 238, 597-603. (Pubitemid 43134372)
116. Shukla-Dave, A., Hricak, H., Kattan, M.W., Pucar, D., Kuroiwa, K., Chen, H.-N., Spector, J., Koutcher, J.A., Zakian, K.L., and Scardino, P.T., 2007, The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU International, 99, 786-793. (Pubitemid 46439567)
117. Kumar, R., Nayyar, R., Kumar, V., Gupta, N.P., Hemal, A.K., Jagannathan, N.R., Dattagupta, S. and Thulkar, S., 2008, Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. Urology, 72, 859-863.
118. Fütterer, J.J., Heijmink, S.W.T.P.J., Scheenen, T.W.J., Veltman, J., Huisman, H.J., Vos, P., Hulsbergen-van de Kaa, C.A., Witjes, J.A., Krabbe, P.F.M., Heerschap, A. and Barentsz, J.O., 2006, Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology, 241,449-458.
119. Girouin, N., Mge-Lechevallier, F., Senes, A.T., Bissery, A., Rabilloud, M., Marchai, J.-M., Colombel, M., Lyonnet, D. and Rouvire, O., 2007, Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? European Radiology, 17, 1498-1509. (Pubitemid 46767598)
120. Jager, G.J., Ruijter, E.T., van de Kaa, CA., de la Rosette, J.J., Oosterhof, G.O., Thornbury, J.R., Ruijs, S.H. and Barentsz, J.O., 1997, Dynamic TurboFLASH subtraction technique for contrastenhanced MR imaging of the prostate: correlation with histopathologic results. Radiology, 203, 645-652.
121. Ogura, K., Maekawa, S., Okubo, K., Aoki, Y., Okada, T., Oda, K., Watanabe, Y., Tsukayama, C., and Arai, Y., 2001, Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology, 57, 721-726.
122. Hara, N., Okuizumi, M., Koike, H., Kawaguchi, M. and Bilim, V., 2005, Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate, 62, 140-147. (Pubitemid 40096780)
123. Vos, P.C., Hambrock, T., Hulsbergen-van de Kaa, CA., Fütterer, J.J., Barentsz, J.O. and Huisman, H.J., 2008, Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. Medical Physics, 35, 888-899. (Pubitemid 351322670)
124. Rouvire, C., Hartman, R.P. and Lyonnet, D., 2006, Prostate MR imaging at high-field strength: evolution or revolution? European Radiology, 16, 276-284. (Pubitemid 43149626)
125. Sato, C., Naganawa, S., Nakamura, T., Kumada, H., Miura, S., Takizawa, O. and Ishigaki, T., 2005, Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. Journal of Magnetic Resonance Imaging, 21, 258-262. (Pubitemid 40280120)
126. Haider, M.A., van der Kwast, T.H., Tanguay, J., Evans, A.J., Hashmi, A.-T., Lockwood, G. and Trachtenberg, J., 2007, Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. American Journal of Roentgenology, 189, 323-328. (Pubitemid 47195916)
127. Kim, C.K., Park, B.K., Lee, H.M. and Kwon, G.Y., 2007, Value of diffusion weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Investigative Radiology, 42, 842-847.
128. Miao, H., Fukatsu, H. and Ishigaki, T., 2007, Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. European Journal of Radiology, 61, 297-302. (Pubitemid 46096691)
129. Morgan, V.A., Kyriazi, S., Ashley, S.E. and deSouza, N.M., 2007, Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiology, 48, 695-703.
130. Shimofusa, R., Fujimoto, H., Akamata, H., Motoori, K., Yamamoto, S., Ueda, T. and Ito, H., 2005, Diffusion-weighted imaging of prostate cancer. Journal of Computer Assisted Tomography, 29, 149-153.
131. Tanimoto, A., Nakashima, J., Kohno, H., Shinmoto, H. and Kuribayashi, S., 2007, Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. Journal of Magnetic Resonance Imaging, 25, 146-152. (Pubitemid 46095209)
132. Yoshimitsu, K., Kiyoshima, K., Irie, H., Tajima, T., Asayama, Y., Hirakawa, M., Ishigami, K., Naito, S. and Honda, H., 2008, Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. Journal of Magnetic Resonance Imaging, 27, 132-139.
133. Mazaheri, Y., Shukla-Dave, A., Hricak, H., Fine, S.W., Zhang, J., Inurrigarro, G., Moskowitz, C.S., Ishill, N.M., Reuter, V.E., Touijer, K., Zakian, K.L. and Koutcher, J.A., 2008, Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology, 246, 480-488.
134. deSouza, N.M., Riches, S.F., Vanas, N.J., Morgan, V.A., Ashley, S.A., Fisher, C., Payne, G.S. and Parker, C., 2008, Diffusionweighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clinical Radiology, 63, 774-782.
135. Tamada, T., Sone, T., Jo, Y., Toshimitsu, S., Yamashita, T., Yamamoto, A., Tanimoto, D. and Ito, K., 2008, Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. Journal of Magnetic Resonance Imaging, 28, 720-726.
136. Choi, Y.J., Kim, J.K., Kim, N., Kim, K.W., Choi, E.K. and Cho, K.S., 2007, Functional MR imaging of prostate cancer. Radiographics, 27, 63-75; discussion 75-77.
137. Issa, B., 2002, In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echoplanar imaging. Journal of Magnetic Resonance Imaging, 16, 196-200.
138. Pickles, M.D., Gibbs, P., Sreenivas, M. and Turnbull, L.W., 2006, Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. Journal of Magnetic Resonance Imaging, 23, 130-134.
139. Macura, K.J., 2008, Multiparametric magnetic resonance imaging of the
140. Smith, E. and Dent, G., 2005, Modern Raman Spectroscopy: A Practical Approach (Chichester: John Wiley & Sons).
141. Krafft,C.andSergo,V.,2006, BiomedicalapplicationsofRamanandinfraredspectroscopy-diagnosetissues. Spectroscopy,20,195-218.(Pubitemid46129068)
142. Bhargava, R., Fernandez, D.C., Hewitt, S.M. and Levin, I.W., 2006, High throughput assessment of cells and tissues: Bayesian classification of spectral metrics from infrared vibrational spectroscopic imaging data. Biochimica Biophysica Acta, 1758, 830-845.
143. Fernandez, D.C., Bhargava, R., Hewitt, S.M. and Levin, I.W., 2005, Infrared spectroscopic imaging for histopathologic recognition. Nature Biotechnology, 23, 469-474. (Pubitemid 41724923)
144. German, M.J., Hammiche, A., Ragavan, N., Tobin, M.J., Cooper, L.J., Matanhelia, S.S., Hindley, A.C., Nicholson, C.M., Fullwood, N.J., Pollock, H.M. and Martin, F.L., 2006, Infrared spectroscopy with multivariate analysis potentially facilitates the segregation of different types of prostate cell. Biophysics Journal, 90, 3783-3795.
145. Harvey, T.J., Henderson, A., Gazi, E., Clarke, N.W., Brown, M., Faria, B.C., Snook, R.D., and Gardner, P., 2007, Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy. Analyst, 132, 292-295. (Pubitemid 46494496)
146. Malins, D.C., Polissar, NL. and Gunselman, S.J., 1997, Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proceedings of the National Academy of Sciences USA, 94, 259-264.
147. Paluszkiewicz, C., Kwiatek, W.M., Banas, A., Kisiel, A., Marcelli, A., and Piccinini, A., 2007, SRFTIR spectroscopic preliminary findings of non-cancerous, cancerous, and hyperplastic human prostate tissues. Vibrational Spectroscopy, 43, 237-242.
148. Gazi, E., Baker, M., Dwyer, J., Lockyer, N.P., Gardner, P., Shanks, J.H., Reeve, R.S., Hart, C.A., Clarke, N.W. and Brown, M.D., 2006, A correlation of FTIR spectra derived from prostate cancer biopsies with Gleason grade and tumour stage. European Urology, 50,750-761. (Pubitemid 44332671)
149. Malins, D.C., Johnson, P.M., Barker, E.A., Polissar, N.L., Wheeler, T.M. and Anderson, K.M., 2003, Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. Proceedings of the National Academy of Sciences USA, 100, 5401-5406.
150. Bogomolny, E., Huleihel, M., Suproun, Y., Sahu, R.K. and Mordechai, S., 2007, Early spectral changes of cellular malignant transformation using Fourier transform infrared microspectroscopy. Journal of Biomedical Optics, 12, 024003.
151. Crow, P., Ritchie, A., Wright, M., Kendall, C. and Stone, N., 2002, Evaluation of Raman spectroscopy to provide a real time optical method for discrimination between normal and abnormal tissue in the prostate. European Urology, Suppl 1, 92-92
152. Crow, P., Stone, N., Kendall, C.A., Uff, J.S., Farmer, J.A.M., Barr, H. and Wright, M.P.J., 2003, The use of Raman spectroscopy to identify and grade prostatic adenocarcinoma in vitro. British Journal of Cancer, 89, 106-108. (Pubitemid 36897944)
153. Crow, P., Molckovsky, A., Stone, N., Uff, J., Wilson, B. and Wong Kee Song, L.-M., 2005, Assessment of fiberoptic near-infrared Raman spectroscopy for diagnosis of bladder and prostate cancer. Urology, 65, 1126-1130.
154. Crow, P., Barrass, B., Kendall, C., Hart-Prieto, M., Wright, M., Persad, R. and Stone, N., 2005, The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines. British Journal of Cancer, 92, 2166-2170.
155. Stone, N., Prieto, M.C.H., Crow, P., Uff, J. and Ritchie, A.W., 2007, The use of Raman spectroscopy to provide an estimation of the gross biochemistry associated with urological pathologies. Analytical and Bioanalytical Chemistry, 387, 1657-1668. (Pubitemid 46309532)
156. Taleb, A., Diamond, J., McGarvey, J.J., Beattie, J.R., Toland, C. and Hamilton, P.W., 2006, Raman microscopy for the chemometric analysis of tumor cells. The Journal of Physical Chemistry B, 110, 19625-19631.
157. Bertaccini,A.,Franceschelli,A.,Schiavina,R.,Marchiori,D.,Baccos,A., Pernetti,R.,Granchi,S.,Biagi,E.,Masotti,L.andMartorana,G.,2008, Accuracyofanewechographicmethod(RULES,radiofrequencyultrasoniclocalestimators) inprostatecancerdiagnosis.AnticancerResearch,28,1883-1886.(Pubitemid351892900)
158. Braeckman, J., Autier, P., Garbar, C., Marichal, M.P., Soviany, C., Nir, R., Nir, D., Michielsen, D., Bleiberg, H., Egevad, L. and Emberton, M., 2008, Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU International, 101, 293-298.
159. Mohamed, S.S. and Salama, M.A., 2008, Prostate cancer spectral multifeature analysis using TRUS images. IEEE Transactions in Medical Imaging, 27, 548-556.
160. Moradi, M., Mousavi, P. and Abolmaesumi, P., 2007, Computeraided diagnosis of prostate cancer with emphasis on ultrasoundbased approaches: a review. Ultrasound in Medicine and Biology, 33, 1010-1028.
161. Scheipers, U., König, K., Sommerfeld, H.J., Garcia-Schuermann, M., Senge, T. and Ermert, H., 2008, Sonohistology-Ultrasonic tissue characterization for prostate cancer diagnostics. Cancer Biomarkers, 4, 227-250.
162. Heijmink, S.W.T.P.J., van Moerkerk, H., Kiemeney, L.A.L.M., Witjes, J.A., Frauscher, F. and Barentsz, J.O., 2006, A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. European Radiology, 16, 927-938.
163. Pallwein, L., Mitterberger, M., Gradl, J., Aigner, F., Horninger, W., Strasser, H., Bartsch, G., zur Nedden, D. and Frauscher, F., 2007, Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Current Opinions in Urology, 17, 39-47.
164. van Moerkerk, H., Heijmink, S.W.T.P.J., Hulsbergen-van de Kaa, C., Barentsz, J.O. and Witjes, J.A., 2006, Computerized threedimensional localization of prostate cancer using contrast-enhanced power Doppler and clustering analysis. European Urology, 50, 762-768; discussion 768-769.
165. Albers, M.J., Bok, R., Chen, A.P., Cunningham, C.H., Zierhut, M.L., Zhang, V.Y., Köhler, S.J., Tropp, J., Hurd, R.E., Yen, Y.-F., Nelson, S.-J., Vigneron, D.B. and Kurhanewicz, J., 2008, Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Research, 68, 8607-8615.
166. Tessem, M.-B., Swanson, M.G., Keshari, K.R., Albers, M.J., Joun, D., Tabatabai, ZL., Simko, J.P., Shinohara, K., Nelson, S.J., Vigneron, D.B., Gribbestad, I.S. and Kurhanewicz, J., 2008, Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using H-I HR-MAS spectroscopy of biopsy tissues. Magnetic Resonance in Medicine, 60, 510-516.
167. Aigner, F., Pallwein, L., Pelzer, A., Schaefer, G., Bartsch, G., zur Nedden, D. and Frauscher, F., 2007, Value of magnetic resonance imaging in prostate cancer diagnosis. World Journal of Urology, 25, 351-359.
168. Thakral, C., Alhariri, J. and Abraham, J.L., 2007, Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications. Contrast Media & Molecular Imaging, 2, 199-205. (Pubitemid 47542596)
169. Chen, M., Dang, H.-D., Wang, J.-Y., Zhou, C., Li, S.-Y., Wang, W.-C., Zhao, W.-F., Yang, Z.-H., Zhong, C.-Y. and Li, G.-Z., 2008, Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Acta Radiology, 49, 602-610.
170. Hambrock, T., Fuetterer, J.J., Huisman, H.J., Hulsbergen-van de Kaa, C., van Basten, J.-P., van Oort, I., Witjes, J.A. and Barentsz, J.O., 2008, Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: Technique and feasibility. Investigative Radiology, 43, 686-694.
171. Tamada, T., Sone, T., Jo, Y., Yamamoto, A., Yamashita, T., Egashira, N., Imai, S., and Fukunaga, M., 2008, Prostate cancer: relationships between post-biopsy hemorrhage and tumor detectability at MR diagnosis. Radiology, 248, 531-539.
172. Anastasiadis, A.G., Lichy, M.P., Nagele, U., Kuczyk, M.A., Hennenlotter, J., Corvin, S., Sievert, K.-D., Claussen, CD., Stenzl, A., and Schlemmer, H.-P., 2008, MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. European Urology, 50, 738-748; discussion 748-749.
173. Fischer, G.S., Iordachita, I., Csoma, C., Tokuda, J., DiMaio, S.P., Tempany, C.M., Hata, N. and Fichtinger, G., 2008, MRI-compatible pneumatic robot for transperineal prostate needle placement. IEEE/ ASME Transactions on Mechatronics, 13, 295-305.
174. Lattouf, J.-B., Grubb, R.L., Lee, S.J., Bjurlin, M.A., Albert, P., Singh, A.K., Ocak, I., Choyke, P. and Coleman, J.A., 2007, Magnetic resonance imaging directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU International, 99, 1041-1046.
175. Muntener, M., Patriciu, A., Petrisor, D., Schär, M., Ursu, D., Song, D.Y. and Stoianovici, D., 2008, Transperineal prostate intervention: robot for fully automated MR imaging-system description and proof of principle in a canine model. Radiology, 247, 543-549.
176. Prieto, M.C.H., Matousek, P., Towrie, M., Parker, A.W., Wright, M., Ritchie, A.W. and Stone, N., 2005, Use of picosecond Kerr-gated Raman spectroscopy to suppress signals from both surface and deep layers in bladder and prostate tissue. Journal of Biomedical Optics, 10, 044006-L. (Pubitemid 43328908)
177. Matousek,P.,2006, InversespatiallyoffsetRamanspectroscopyfordeepnoninvasiveprobingofturbidmedia. AppliedSpectroscopy,60,1341-1347.(Pubitemid44876070)
178. Hanlon, E.B., Manoharan, R., Koo, T.-W., Shafer, K.E., Motz, J.T., Fitzmaurice, M., Kramer, J.R., Itzkan, I., Dasari, R.R. and Feld, M.S., 2000, Topical Review: Prospects for in vivo Raman spectroscopy. Physics in Medicine and Biology, 45, R1-R59.
179. Komachi, Y., Sato, H., Aizawa, K. and Tashiro, H., 2005, Microoptical fiber probe for use in an intravascular Raman endoscope. Applied Optics, 44, 4722-4732. (Pubitemid 41145920)
180. Bhargava, R., 2007, Towards a practical Fourier transform infrared chemical imaging protocol for cancer histopathology. Analytical and Bioanalytical Chemistry, 389, 1155-1169.
181. Awsare, N.S., Green, J.S.A., Aldwinckle, B., Hanbury, D.C., Boustead, G.B. and McNicholas, T.A., 2008, The measurement of psychological distress in men being investigated for the presence of prostate cancer. Prostate Cancer and Prostatic Diseases, 11, 384-389.
182. Phipps, S., 2006, Prostate tissue stiffness as measured with a resonance sensor system: a study on silicone and human prostate tissue in vitro. Medical & Biological Engineering & Computing, 44, 941-943.
183. Dubbelman, Y.D., Wildhagen, M.F. and Dohle, G.R., 2008, Penile vascular evaluation and sexual function before and after radical retropubic prostatectomy: 5-year follow-up. International Journal of Andrology, 31, 483-489.
184. Gonzalgo, M.L., Patil, N., Su, L.-M. and Patel, V.R., 2008, Minimally invasive surgical approaches and management of prostate cancer. Urologie Clinics of North America, 35, 489-504.
185. Singh, A.K., 2008, Editorial comment on: contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. European Urology, 54, 993.